Overview
Veronica Blanco-Parra practices in Madrid, Spain. Ms. Blanco-Parra is highly rated in 4 conditions, according to our data. Her top areas of expertise are Kimura Disease, Epidermoid Cyst, Hyperkeratosis Lenticularis Perstans, Bazex Syndrome, and Lymphadenectomy.
Her clinical research consists of co-authoring 69 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Kimura DiseaseMs. Blanco-Parra isDistinguished. Learn about Kimura Disease.
- Advanced
- Bazex SyndromeMs. Blanco-Parra isAdvanced. Learn about Bazex Syndrome.
- Epidermoid CystMs. Blanco-Parra isAdvanced. Learn about Epidermoid Cyst.
- Hyperkeratosis Lenticularis PerstansMs. Blanco-Parra isAdvanced. Learn about Hyperkeratosis Lenticularis Perstans.
- Experienced
- Adult Soft Tissue SarcomaMs. Blanco-Parra isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Anaplastic Large Cell LymphomaMs. Blanco-Parra isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Autosomal Recessive HypotrichosisMs. Blanco-Parra isExperienced. Learn about Autosomal Recessive Hypotrichosis.
- BullaeMs. Blanco-Parra isExperienced. Learn about Bullae.
- Bullous PemphigoidMs. Blanco-Parra isExperienced. Learn about Bullous Pemphigoid.
- Chronic T-Cell Leukemia (CTCL)Ms. Blanco-Parra isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).